ReviewiScience2025
Generative artificial intelligence in diabetes healthcare.
Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The Design-Driven Innovation Path of Human-Centered Artificial Intelligence in the Field of Healthcare: Theory, Practice, and Future Prospects.Healthcare (Basel, Switzerland) · 2026Review
- Nanostructured electrode materials and flexible-substrate engineering for wearable multi-analyte biosensors in diabetes monitoring and personalized care: a comprehensive review.Journal of materials science. Materials in medicine · 2026Review
- Governing Patient-Facing AI-Generated Video in Digital Health: A Risk-and-Ethics Matrix for Deployment, Monitoring, and Change Control.Journal of medical Internet research · 2026Article
- Navigating the AI Revolution: A New Chapter for the Diabetes and Metabolism Journal.Diabetes & metabolism journal · 2026Article
- Artificial Intelligence for Diabetes Complication Prediction: A Systematic Review of Current Applications and Future Directions.Journal of diabetes science and technology · 2025Review
- Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review.Annals of translational medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid advancement of generative artificial intelligence (AI) has been fueled by breakthroughs in large language models and applications across diverse domains, from creative content to scientific discovery. Its strength lies in modeling, simulating, and generating high-fidelity data. In diabetes care, generative AI enables solutions to challenges such as data scarcity, patient variability, and personalization. This article explores key deep generative models, including variational autoencoders, generative adversarial networks, transformers, and diffusion models applied to tabular, time series, image, and text data. These models enable synthetic patient data generation, dataset augmentation, glucose-insulin dynamics simulation, and the development of virtual coaches and digital twins. Despite these advances, challenges persist, including model instability, high data requirements, and output interpretability. This article reviews the current literature and outlines opportunities, limitations, and ethical considerations for the use of generative AI in diabetes healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.